Summary
The polypeptide hormone prolactin (Prl), acting through its cell surface receptors, promotes growth and differentiation in normal and malignant breast cells. We demonstrate herein that two Prl-responsive cell lines, NOG-8 normal mouse mammary epithelial and T47D human breast cancer cells, respond to Prl by rapid and transient activation of a series of kinases.Raf-1 was activated within 2–5 min of Prl treatment. This was followed rapidly by activation of MEK (MAP kinase kinase) and MAP kinase activity in these cells. Increased MAP kinase activity was accompanied by tyrosine phosphorylation of both the 42 kDa and 44 kDa isoforms. The tyrosine kinase inhibitors genestein and tyrphostin blocked the increase in MAP kinase activity as well as Prl induced growth of the T47D cells. These results indicate that the Prl receptor, after binding to Prl in mammary cells, activates theraf-MEK-MAP kinase pathway for signal transduction leading to mitogenesis.
References
Vonderhaar BK: Prolactin: transport, function, and receptors in mammary gland development and differentiation. In: Neville MC, Daniel CW (eds) The Mammary Gland. Plenum Publishing Corporation, New York, NY, 1987, pp 383–438
Vonderhaar BK, Biswas R: Prolactin effects and regulation of its receptors in human mammary tumor cells. In: Medina D, Kidwell W, Hepner G, Anderson E (eds) Cellular and Molecular Biology of Mammary Cancer. Plenum Publishing Corp., New York, NY, 1987, pp 205–219
Bonneterre J, Peyrat JP, Vandewalle B, Beuscart R, Vie MC, Cappelaere P: Prolactin receptors in human breast cancer. Eur J Cancer Clin Oncol 18: 1157–1162, 1982
Ginsburg E, Vonderhaar BK: Prolactin synthesis and secretion by human breast cancer cells. Cancer Res 55: 2591–2595, 1995
Kelly PA, Djiane J, Postel-Vinay MC, Edery M: The prolactin/growth hormone receptor family. Endocrine Rev 12: 235–251, 1991
Argetsinger LS, Campbell GS, Yang X, Witthuhn BA, Silvennoinen O, Ihle JN, Carter Su C: Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74: 237–244, 1993
Silvennoinen O, Witthuhn BA, Quelle FW, Cleveland JL, Taolin Y, Ihle JN: Structure of the murine Jak2 protein-kinase and its role in interleukin 3 signal transduction. Proc Natl Acad Sci USA 90: 8429–8433, 1993
Witthuhn BA, Quelle FW, Silvennoinen O, Tang B, Miura O, Ihle JN: JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74: 227–236, 1993
Darnell JE Jr, Kerr IM, Stark GR: Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264: 1415–1421, 1994
Banerjee R, Ginsburg E, Vonderhaar BK: Characterization of a monoclonal antibody against human prolactin receptors. Int J Cancer 55: 712–721, 1993
Banerjee R, Cutler ML, Vonderhaar BK: Repression of lactogen binding to NOG-8 mammary epithelial cells by V-Ras. Mol Cell Differentiation 1: 215–231, 1993
Wakao H, Gouilleux F, Groner B: Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO J 13: 2182–2191, 1994
Alessandrini A, Crews CM, Erikson RL: Phorbol ester stimulates a protein-tyrosine/threonine kinase that phosphorylates and activates theERK-1 gene product. Proc Natl Acad Sci USA 89: 8200–8204, 1992
Crews CM, Erikson RL: Extracellular signals and reversible protein phosphorylation: what to Mek of it all. Cell 74: 215–217, 1993
Pelech SL, Sanghera JS: MAP kinases: charting the regulatory pathways. Science 257: 1355–1356, 1992
Nishida E, Gotah Y: The MAP kinase cascade is essential for diverse signal transduction pathways. TIBS 18: 128–131, 1993
Marquardt B, Frith D, Stabel S: Signalling from TPA to MAP kinase requires protein kinase C, raf and MEK: reconstitution of the signalling pathwayin vitro. Oncogene 9: 3213–3218, 1994
Anderson NG, Maller JL, Tonks NK, Sturgill TW: Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase. Nature 343: 651–653, 1990
Cobb MH, Robbins DJ, Boulton TG: ERKs, extracellular signal-regulated MAP-2 kinases. Curr Opin Cell Biol 3: 1025–1032, 1991
Banerjee R, Vonderhaar BK: Prolactin induced protein kinase C activity in a mouse mammary epithelial cell line NOG-8. Mol Cell Endocrinol 90: 61–67, 1992
Owens RB, Smith HS, Hackett AJ: Epithelial cell culture from glandular tissue of mice. J Natl Cancer Inst 53: 261–266, 1974
Biswas R, Vonderhaar BK: Role of serum in prolactin responsiveness of MCF-7 human breast cancer cells in long term tissue culture. Cancer Res 47: 3509–3514, 1987
Clevenger CV, Torigoe T, Reed JC: Prolactin induces rapid phosphorylation and activation of prolactin receptor-associated RAF-1 kinase in a T-cell line. J Biol Chem 269: 5559–5565, 1994
Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685, 1970
Erikson E, Maller YL:In vivo phosphorylation and activation of ribosomal protein S6 kinases during xenopus oocyte maturation. J Biol Chem 264: 13711–13717, 1989
Muslin AJ, MacNicol AM, Williams LT: Raf-1 protein kinase is important for progesterone-induced xenopus oocyte maturation and acts downstream of mos. Mol Cell Biol 13: 4197–4202, 1993
Williams NG, Roberts TM, Li P: Both p21ras and pp60v-src are required, but neither alone is sufficient, to activate the raf-1 kinase. Proc Natl Acad Sci USA 89: 2922–2926, 1992
Reddy KB, Mangold GL, Tandon AK, Yoneda T, Mundy GR, Zilberstein A, Osborne CK: Inhibition of breast cancer cell growthin vitro by a tyrosine kinase inhibitor. Cancer Res 52: 3636–3641, 1992
Kelly PA, Ali S, Rozakis M, Goujon L, Nagano M, Pellegrini I, Gould D, Djiane J, Edery M, Finidori J, Postel-Vinay MC: The growth hormone/prolactin receptor family. Rec Prog Hormone Res 48: 123–164, 1993
Clevenger CV, Chang WP, Ngo W, Pasha TLM, Montone KT, Tomaszewski JE: Expression of prolactin and prolactin receptor in human breast carcinoma. Am J Pathol 146: 695–705, 1995
Pages G, Lenormand P, L'Allemain G, Chambard JC, Meloche S, Pouyssegur J: Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc Natl Acad Sci USA 90: 8319–8323, 1993
Troppmair J, Bruder JT, Munoz H, Lloyd PA, Kyriakis J, Banerjee P, Avruch J, Rapp UR: Mitogen-activated protein kinase/extracellular signal-regulated protein kinase activation of oncogenes, serum, and 12-tetradecanoylphorbol-13-acetate requires raf and is necesary for transformation. J Biol Chem 269: 7030–7035, 1994
Frost JA, Geppert TD, Cobb MH, Fermisco JR: A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-ras, phorbol 12-myristate 13-acetate, and serum. Proc Natl Acad Sci USA 91: 3844–3848, 1994
Clevenger CV, Medaglia MV: The protein tyrosine kinase p59fyn is associated with prolactin (PRL) receptor and is activated by PRL stimulation of T-lymphocytes. Mol Endocrinol 8: 674–681, 1994
Piccoletti R, Maroni P, Bendinelli P, Bernelli-Zazzera A: Rapid stimulation of mitogen-activated protein kinase of rat liver by prolactin. Biochem J 303: 429–433, 1994
Buckley AR, Rao YP, Buckley DJ, Gout PW: Prolactin-induced phosphorylation and nuclear translocation of MAP kinase in Nb2 lymphoma cells. Biochem Biophys Res Commun 204: 1158–1164, 1994
Carey G, Liberti JP: Coupling of tyrosine and S6 kinase activities to lactogen-induced mitogenesis. FASEB J 8: A910 (Abstract), 1994
Rui H, Lebrun JJ, Kirken RA, Kelly PA, Farrar WL: JAK2 activation and cell proliferation induced by antibody-mediated prolactin receptor dimerization. Endocrinology 135: 1299–1306, 1994
Rui H, Kirken RA, Farrar WL: Activation of receptor-associated tyrosine kinase JAK2 by prolactin. J Biol Chem 269: 5364–5368, 1994
Waters MJ, Daniel N, Bignon C, Djiane J: The rabbit mammary gland prolactin receptor is tyrosine phosphorylated in response to prolactinin vivo andin vitro. J Biol Chem 270: 5136–5143, 1995
VanderKuur J, Allevato G, Billestrup N, Norstedt G, Carter-Su C: Growth hormone-promoted tyrosyl phosphorylation of SHC proteins and SHC association with Grb2. J Biol Chem 270: 7587–7593, 1995
David M, Petricoin EF, Igarashi KI, Feldman GM, Finbloom DS, Larner AC: Prolactin activates the interferonregulated p91 transcription factor and the JAK2 kinase by tyrosine phosphorylation. Proc Natl Acad Sci USA 91: 7174–7178, 1994
Sidis Y, Horseman ND: Prolactin induces rapid p95/p70 tyrosine phosphorylation, and protein binding to GAS-like sites in theanxlcp35 andc-fos genes. Endocrinology 134: 1979–1985, 1994
Standke GJR, Meier VS, Groner B: Mammary gland factor activated by prolactin in mammary epithelial cells and acute-phase response factor activated by interleukin-6 in liver cells share DNA binding and transactivation potential. Mol Endocrinol 8: 469–477, 1994
Moller C, Hansson A, Enberg B, Lobie PE, Norstedt G: Growth hormone (GH) induction of tyrosine phosphorylation and activation of mitogen-activated protein kinases in cells transfected with the rat GH receptor cDNA. J Biol Chem 267: 23403–23408, 1992
Sotiropoulos A, Perrot-Applanat M, Dinerstein H, Pallier A, Postel-Vinay MC, Finidori J, Kelly PA: Distinct cytoplasmic regions of the growth hormone receptor are required for activation of JAK2, mitogen-activated protein kinase, and transcription. Endocrinology 135: 1292–1298, 1994
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Das, R., Vonderhaar, B.K. Activation ofraf-1, MEK, and MAP kinase in prolactin responsive mammary cells. Breast Cancer Res Tr 40, 141–149 (1996). https://doi.org/10.1007/BF01806209
Issue Date:
DOI: https://doi.org/10.1007/BF01806209